ISU Abxis Co., Ltd.
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety and Efficacy of Fabagal® (Agalsidase Beta) in Patients With Fabry Disease (NCT06081062) | ISU Abxis Co., Ltd. | 2023-04-14 |
| A Phase I Study to Compare Abcertin and EU-sourced Cerezyme® in Healthy Volunteers (NCT04787887) | ISU Abxis Co., Ltd. | 2020-01-29 |
| Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors (NCT03552406) | ISU Abxis Co., Ltd. | 2018-04-27 |
Track ISU Abxis Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.